Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Jing Xie,1 Ning Li,1 Xiaoyan Jiang,1 Liyin Chai,1 Jian-Jun Chen,2 Wuquan Deng11Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People’s Republic of China; 2Institute of Life Sciences, Chongqing Medical...

Full description

Bibliographic Details
Main Authors: Xie J, Li N, Jiang X, Chai L, Chen JJ, Deng W
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
repaglinide
glimepiride
metformin
diabetes
meta-analysis
Online Access:https://www.dovepress.com/short-term-efficacy-and-safety-of-repaglinide-versus-glimepiride-as-au-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/short-term-efficacy-and-safety-of-repaglinide-versus-glimepiride-as-au-peer-reviewed-article-DMSO

Similar Items